Search results for " Cannabidiol"

showing 4 items of 4 documents

Binge-like alcohol exposure in adolescence: behavioural, neuroendocrine and molecular evidence of abnormal neuroplasticity … and return

2021

Binge alcohol consumption among adolescents affects the developing neural networks underpinning reward and stress processing in the nucleus accumbens (NAc). This study explores in rats the long-lasting effects of early intermittent exposure to intoxicating alcohol levels at adolescence, on: (1) the response to natural positive stimuli and inescapable stress

Binge alcohol drinkingmedicine.medical_specialtySettore BIO/14 - FARMACOLOGIAQH301-705.5Medicine (miscellaneous)Nucleus accumbensArticleGeneral Biochemistry Genetics and Molecular Biology03 medical and health sciences0302 clinical medicineDopamineDopamine receptor D2Internal medicineNeuroplasticityMedicineCannabidiol[SDV.NEU] Life Sciences [q-bio]/Neurons and Cognition [q-bio.NC]Biology (General)030304 developmental biologyDopamine transporter0303 health sciencesbiologyTyrosine hydroxylasebusiness.industryDopaminergicAdolescenceEndocrinologybiology.proteinNucleus accumbens[SDV.NEU]Life Sciences [q-bio]/Neurons and Cognition [q-bio.NC]Adolescence Binge alcohol drinking Cannabidiol Nucleus accumbensbusinessCannabidiol030217 neurology & neurosurgerymedicine.drug
researchProduct

Cannabis Influences the Putative Cytokines-Related Pathway of Epilepsy among Egyptian Epileptic Patients

2019

The study aims to investigate: (1) the prevalence of cannabis among epileptic patients seen at Mansoura University Hospital, (2) serum levels and gene expression of cytokines in epilepsy patients and the controls. and (3) the possibility that cannabis use affects the cytokine levels in epilepsy patients, triggering its future use in treatment. We recruited 440 epilepsy patients and 200 controls matched for age, gender, and ethnicity. Of the epileptic patients, 37.5% demonstrated lifetime cannabis use with a mean duration of 15 &plusmn

cannabismedicine.medical_specialtypurified cannabidiol (cbd)inflammatory cytokinesmedicine.medical_treatmenttreatment-resistant epilepsyArticlelcsh:RC321-571Proinflammatory cytokine03 medical and health sciencesEpilepsy0302 clinical medicineInternal medicinemedicineanticonvulsant drugslcsh:Neurosciences. Biological psychiatry. Neuropsychiatryseizures030304 developmental biology0303 health sciencesbiologybusiness.industryGeneral NeuroscienceInterleukintetrahydrocannabinol (thc)Cannabis useUniversity hospitalbiology.organism_classificationmedicine.diseaseCytokineepilepsyTumor necrosis factor alphaCannabisbusiness030217 neurology & neurosurgeryBrain Sciences
researchProduct

A Low Dose of Pure Cannabidiol Is Sufficient to Stimulate the Cytotoxic Function of CIK Cells without Exerting the Downstream Mediators in Pancreatic…

2022

Despite numerous studies conducted over the past decade, the exact role of the cannabinoid system in cancer development remains unclear. Though research has focused on two cannabinoid receptors (CB1, CB2) activated by most cannabinoids, CB2 holds greater attention due to its expression in cells of the immune system. In particular, cytokine-induced killer cells (CIKs), which are pivotal cytotoxic immunological effector cells, express a high-level of CB2 receptors. Herein, we sought to investigate whether inducing CIK cells with cannabidiol can enhance their cytotoxicity and if there are any possible counter effects in its downstream cascade of phosphorylated p38 and CREB using a pancreatic d…

cytokine-induced killer cells; cannabidiol; pancreatic cancerpancreatic cancer.CannabinoidsOrganic ChemistryGeneral MedicineCatalysisComputer Science ApplicationsInorganic ChemistryPancreatic NeoplasmsReceptor Cannabinoid CB2Cytokine-Induced Killer CellsReceptor Cannabinoid CB1CannabidiolHumanslipids (amino acids peptides and proteins)Physical and Theoretical Chemistrycytokine-induced killer cellMolecular BiologySpectroscopyInternational Journal of Molecular Sciences; Volume 23; Issue 7; Pages: 3783
researchProduct

The CANNA-TICS Study Protocol: A Randomized Multi-Center Double-Blind Placebo Controlled Trial to Demonstrate the Efficacy and Safety of Nabiximols i…

2020

Background: Gilles de la Tourette syndrome (TS) is a chronic neuropsychiatric disorder characterized by motor and vocal tics. First-line treatments for tics are antipsychotics and tic-specific behavioral therapies. However, due to a lack of trained therapists and adverse events of antipsychotic medication many patients seek alternative treatment options including cannabis. Based on the favorable results obtained from case studies on different cannabis-based medicines as well as two small randomized controlled trials using delta-9-tetrahydrocannabinol (THC), we hypothesize that the cannabis extract nabiximols can be regarded as a promising new and safe treatment strategy in TS.Objective: To …

tourette syndromemedicine.medical_specialtyTHCTicslcsh:RC435-571NabiximolsPlacebo-controlled studynabiximolsPlaceboTourette syndromelaw.inventionStudy Protocol03 medical and health sciencescannabidioltetrahydrocannabinolcannabinoids0302 clinical medicineRandomized controlled triallawInternal medicinelcsh:Psychiatrymental disordersmedicinechronic tic disorderPsychiatrybusiness.industryticsnabiximols ; tetrahydrocannabinol ; cannabidiol ; chronic tic disorder ; tourette syndrome ; THC ; tics ; Tourette-Syndrom ; cannabinoidsmedicine.disease030227 psychiatryClinical trialPsychiatry and Mental healthChronic Tic Disorderbusiness030217 neurology & neurosurgerymedicine.drugFrontiers in Psychiatry
researchProduct